Unlock Premium for Just $9.99/Month – Special Launch Offer, Limited Time Only
Get Premium
RYTM Rhythm Pharmaceuticals Inc
- Stocks
- Healthcare
- NASDAQ: RYTM
Price (delayed)
$65.44
Market cap
$4.16B
P/E Ratio
N/A
Dividend/share
N/A
EPS
-$2.81
Enterprise value
$4.06B
Rhythm is a commercial-stage biopharmaceutical company committed to transforming the treatment paradigm for patients living with rare genetic diseases of obesity. Early-onset severe obesity may result from genetic variants within
Highlights
The gross profit has soared by 51% YoY and by 5% from the previous quarter
RYTM's revenue is up by 49% YoY and by 5% QoQ
Rhythm Pharmaceuticals's equity has plunged by 69% YoY and by 13% from the previous quarter
The quick ratio has declined by 25% year-on-year
Key stats
What are the main financial stats of RYTM
Market
Valuations
Earnings
Shares outstanding
63.62M
Market cap
$4.16B
Enterprise value
$4.06B
Price to earnings (P/E)
N/A
Price to book (P/B)
218.36
Price to sales (P/S)
30.15
EV/EBIT
N/A
EV/EBITDA
N/A
EV/Sales
29.67
Revenue
$136.86M
Gross profit
$122.65M
Operating income
-$172.62M
Net income
-$168.69M
EBIT
-$147.87M
EBITDA
-$146.33M
Free cash flow
-$113.49M
Per share
Balance sheet
Liquidity
EPS
-$2.81
EPS diluted
-$2.81
Free cash flow per share
-$1.8
Book value per share
$0.3
Revenue per share
$2.17
TBVPS
$6.04
Total assets
$386.69M
Total liabilities
$223.6M
Debt
$4.06M
Equity
$18.95M
Working capital
$257.47M
Debt to equity
0.21
Current ratio
3.3
Quick ratio
2.98
Net debt/EBITDA
0.7
Margins
Efficiency
Dividend
EBITDA margin
-106.9%
Gross margin
89.6%
Net margin
-123.3%
Operating margin
-126.1%
Return on assets
-45.7%
Return on equity
-762.8%
Return on invested capital
-81.1%
Return on capital employed
-53.8%
Return on sales
-108%
Dividend yield
N/A
DPS
N/A
Payout ratio
N/A
RYTM stock price
How has the Rhythm Pharmaceuticals stock price performed over time
Intraday
3.56%
1 week
2.8%
1 month
6.7%
1 year
53.36%
YTD
16.9%
QTD
3.56%
Financial performance
How have Rhythm Pharmaceuticals's revenue and profit performed over time
Revenue
$136.86M
Gross profit
$122.65M
Operating income
-$172.62M
Net income
-$168.69M
Gross margin
89.6%
Net margin
-123.3%
The net margin has surged by 59% year-on-year and by 38% since the previous quarter
The operating margin has soared by 57% YoY and by 38% from the previous quarter
The gross profit has soared by 51% YoY and by 5% from the previous quarter
RYTM's revenue is up by 49% YoY and by 5% QoQ
Price vs fundamentals
How does RYTM's price correlate with its fundamentals
Growth
What is Rhythm Pharmaceuticals's growth rate over time
Valuation
What is Rhythm Pharmaceuticals stock price valuation
P/E
N/A
P/B
218.36
P/S
30.15
EV/EBIT
N/A
EV/EBITDA
N/A
EV/Sales
29.67
The EPS has grown by 39% YoY and by 35% from the previous quarter
Rhythm Pharmaceuticals's equity has plunged by 69% YoY and by 13% from the previous quarter
RYTM's P/B is 28% above its last 4 quarters average of 171.1
RYTM's price to sales (P/S) is 98% lower than its 5-year quarterly average of 1958.8 but 16% higher than its last 4 quarters average of 25.9
RYTM's revenue is up by 49% YoY and by 5% QoQ
Efficiency
How efficient is Rhythm Pharmaceuticals business performance
The ROS has soared by 61% YoY and by 41% from the previous quarter
The ROA has grown by 48% YoY and by 40% from the previous quarter
Rhythm Pharmaceuticals's return on invested capital has increased by 42% YoY and by 40% QoQ
The ROE has grown by 3.5% from the previous quarter
Dividends
What is RYTM's dividend
DPS
N/A
Dividend yield
N/A
Payout ratio
N/A
There are no recent dividends present for RYTM.
Financial health
How did Rhythm Pharmaceuticals financials performed over time
The total assets is 73% more than the total liabilities
The total assets has grown by 50% YoY
The quick ratio has declined by 25% year-on-year
The debt is 79% smaller than the equity
Rhythm Pharmaceuticals's equity has plunged by 69% YoY and by 13% from the previous quarter
The debt to equity is up by 17% since the previous quarter
All financial data is based on trailing twelve months (TTM) periods - updated quarterly, unless otherwise specified.